These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 25185137

  • 21. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N, Sokoloff A, Kornak J, Leva NV, Mendiola ML, Levison J, Feakins C, Shannon M, Cohan D.
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [Abstract] [Full Text] [Related]

  • 22. Outcomes of starting first-line antiretroviral therapy in hepatitis B virus/HIV-coinfected patients in Ghana.
    Chadwick D, Ankcorn M, Sarfo F, Phillips R, Fox Z, Garcia A, Appiah L, Bedu-Addo G, Geretti AM.
    J Antimicrob Chemother; 2012 Dec; 67(12):2939-42. PubMed ID: 22915461
    [Abstract] [Full Text] [Related]

  • 23. Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern India.
    Sundaram M, Saghayam S, Priya B, Venkatesh KK, Balakrishnan P, Shankar EM, Murugavel KG, Solomon S, Kumarasamy N.
    Int J Infect Dis; 2008 Nov; 12(6):e61-6. PubMed ID: 18621564
    [Abstract] [Full Text] [Related]

  • 24. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.
    Saint-Marc T, Partisani M, Poizot-Martin I, Bruno F, Rouviere O, Lang JM, Gastaut JA, Touraine JL.
    AIDS; 1999 Sep 10; 13(13):1659-67. PubMed ID: 10509567
    [Abstract] [Full Text] [Related]

  • 25. Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.
    Rotger M, Bayard C, Taffé P, Martinez R, Cavassini M, Bernasconi E, Battegay M, Hirschel B, Furrer H, Witteck A, Weber R, Ledergerber B, Telenti A, Tarr PE, Swiss HIV Cohort Study.
    Circ Cardiovasc Genet; 2009 Dec 10; 2(6):621-8. PubMed ID: 20031643
    [Abstract] [Full Text] [Related]

  • 26. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD, HepaI.Co.N.A. Study Group, Italian Cohort Naive for Antiretrovirals Study Group.
    Clin Infect Dis; 2005 Jun 15; 40(12):e101-9. PubMed ID: 15909251
    [Abstract] [Full Text] [Related]

  • 27. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.
    Martinez E, Mocroft A, García-Viejo MA, Pérez-Cuevas JB, Blanco JL, Mallolas J, Bianchi L, Conget I, Blanch J, Phillips A, Gatell JM.
    Lancet; 2001 Feb 24; 357(9256):592-8. PubMed ID: 11558485
    [Abstract] [Full Text] [Related]

  • 28. [Adipokines and highly active antiretroviral therapy related lipodystrophy: clinical study of 52 cases].
    Tao MM, Zhang L, Qiu ZF, Xie J, Han Y, Yu W, Li M, Li TS.
    Zhonghua Yi Xue Za Zhi; 2009 Apr 07; 89(13):867-71. PubMed ID: 19671283
    [Abstract] [Full Text] [Related]

  • 29. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida.
    Enferm Infecc Microbiol Clin; 2012 Jun 07; 30(6):e1-89. PubMed ID: 22633764
    [Abstract] [Full Text] [Related]

  • 30. Non-traditional adipokines in pediatric HIV-related lipodystrophy: a-FABP as a biomarker of central fat accumulation.
    Theodoridou K, Margeli A, Spoulou V, Bathrellou I, Skevaki C, Chrousos GP, Papassotiriou I, Kanaka-Gantenbein C.
    Scand J Clin Lab Invest; 2014 Jan 07; 74(1):67-73. PubMed ID: 24266781
    [Abstract] [Full Text] [Related]

  • 31. Effect of adiponectin-encoding gene ADIPOQ single nucleotide polymorphisms +45 and +276 on serum lipid levels after antiretroviral therapy in Japanese patients with HIV-1-infection.
    Kato H, Ohata A, Samukawa S, Ueda A, Ishigatsubo Y.
    J Int Med Res; 2016 Apr 07; 44(2):297-306. PubMed ID: 26831403
    [Abstract] [Full Text] [Related]

  • 32. Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapy.
    Galli M, Ridolfo AL, Adorni F, Cappelletti A, Morelli P, Massetto B, Piazza M, Gianelli E, Vaccarezza M, Gervasoni C, Moroni M.
    Antivir Ther; 2003 Aug 07; 8(4):347-54. PubMed ID: 14518704
    [Abstract] [Full Text] [Related]

  • 33. A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy.
    Cavalcanti RB, Raboud J, Shen S, Kain KC, Cheung A, Walmsley S.
    J Infect Dis; 2007 Jun 15; 195(12):1754-61. PubMed ID: 17492590
    [Abstract] [Full Text] [Related]

  • 34. Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d'Ivoire.
    Adjé-Touré CA, Cheingsong R, Garcìa-Lerma JG, Eholié S, Borget MY, Bouchez JM, Otten RA, Maurice C, Sassan-Morokro M, Ekpini RE, Nolan M, Chorba T, Heneine W, Nkengasong JN.
    AIDS; 2003 Jul 15; 17 Suppl 3():S49-54. PubMed ID: 14565609
    [Abstract] [Full Text] [Related]

  • 35. Changes in Body Fat Distribution on Dual-Energy X-Ray Absorptiometry in Black South Africans Starting First-Line Antiretroviral Therapy.
    Abrahams Z, Levitt N, Lesosky M, Maartens G, Dave J.
    AIDS Patient Care STDS; 2016 Oct 15; 30(10):455-462. PubMed ID: 27749108
    [Abstract] [Full Text] [Related]

  • 36. Effect of different antiretroviral drug regimens on body fat distribution of HIV-infected South African women.
    Goedecke JH, Micklesfield LK, Levitt NS, Lambert EV, West S, Maartens G, Dave JA.
    AIDS Res Hum Retroviruses; 2013 Mar 15; 29(3):557-63. PubMed ID: 23330599
    [Abstract] [Full Text] [Related]

  • 37. Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women.
    McDermott AY, Shevitz A, Knox T, Roubenoff R, Kehayias J, Gorbach S.
    Am J Clin Nutr; 2001 Nov 15; 74(5):679-86. PubMed ID: 11684538
    [Abstract] [Full Text] [Related]

  • 38. Long-term fat redistribution in ARV-naïve HIV+ patients initiating a non-thymidine containing regimen in clinical practice.
    Ferrer E, Navarro A, Curto J, Medina P, Rozas N, Barrera G, Saumoy M, Tiraboschi JM, Gomez C, Podzamczer D.
    J Int AIDS Soc; 2014 Nov 15; 17(4 Suppl 3):19553. PubMed ID: 25394060
    [Abstract] [Full Text] [Related]

  • 39. Lower serum adiponectin level is associated with lipodystrophy among HIV-infected men in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN) study.
    Klos B, Patel P, Rose C, Bush T, Conley L, Kojic EM, Henry K, Brooks JT, Hammer J, SUN study investigators.
    HIV Med; 2019 Sep 15; 20(8):534-541. PubMed ID: 31149766
    [Abstract] [Full Text] [Related]

  • 40. Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial.
    Mulligan K, Parker RA, Komarow L, Grinspoon SK, Tebas P, Robbins GK, Roubenoff R, Dubé MP.
    J Acquir Immune Defic Syndr; 2006 Apr 15; 41(5):590-7. PubMed ID: 16652032
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.